Mycoplasma hyopneumoniae is the principal aetiological agent of enzootic pneumonia (EP), a chronic respiratory disease that affects mainly finishing pigs. Although major efforts to control M. hyopneumoniae infection and its detrimental effects have been made, significant economic losses in pig production worldwide due to EP continue. M. hyopneumoniae is typically introduced into pig herds by the purchase of subclinically infected animals or, less frequently, through airborne transmission over short distances. Once in the herd, M. hyopneumoniae may be transmitted by direct contact from infected sows to their offspring or between pen mates.
Introduction
Mycoplasma hyopneumoniae is the principal aetiological agent responsible for enzootic pneumonia (EP) in pigs. Other pathogens such as Pasteurella multocida, Actinobacillus pleuroneumoniae, Mycoplasma hyorhinis, Streptococcus suis, Haemophilus parasuis, Bordetella bronchiseptica and Arcanobacterium pyogenes are also frequently involved (Thacker, 2006) . The disease is characterised by high morbidity and low mortality and although pigs of all ages are susceptible to M. hyopneumoniae infection, EP is usually not observed in animals younger than 6 weeks of age. The prevalence of EP is particularly high in animals of mid-finishing to slaughter age and the severity of clinical signs is dictated by the strain of M. hyopneumoniae involved, infection pressure, the presence of secondary infections and by environmental conditions. When M. hyopneumoniae infection is not complicated by concomitant pathogens, the disease can take a subclinical course with mild clinical signs consisting of chronic, non-productive cough, reduced rate of average daily weight gain (ADWG) and reduced feed conversion efficiency. When secondary pathogens are involved, clinical signs include laboured breathing and pyrexia, and deaths may occur (Maes et al., 1996) .
M. hyopneumoniae is intimately involved in the pathogenesis of porcine respiratory disease complex (PRDC), a disease involving both bacterial (those potentially involved in EP listed above) and viral (porcine reproductive and respiratory syndrome virus [PRRSV] , porcine circovirus type 2, Aujeszky's disease virus, swine influenza viruses [SIVs] and porcine respiratory coronavirus) pathogens. Porcine respiratory disease complex typically affects finishing pigs of between 14 and 20 weeks of age and is characterised clinically by depressed growth rate and feed conversion efficiency and by anorexia, fever, cough, and dyspnoea. This disease has been referred to as the '18 week wall' given its higher prevalence in pigs of this age (Dee, 1996) .
Although improved management methods and the judicious use of medication and vaccination have greatly alleviated the detrimental effects of EP on herd health and on carcass quality, EP-associated economic losses remain important within pig production worldwide (Thacker, 2006) . These losses are mainly due to decreased ADWG, increased feed conversion ratio, increased medication costs and, in some cases, to higher mortality rates (Maes et al., 1998) . No recent estimates of the financial losses attributable to EP are available and these are likely to vary considerably between herds (Maes et al., 1998) .
A sound knowledge of the routes of transmission of M. hyopneumoniae and of the other pathogens associated with EP is necessary to control the disease as well as to understand the factors that influence the pathogenesis. In the next sections we review current knowledge of M. hyopneumoniae transmission and seroconversion dynamics in different swine production systems and compare the different epidemiological tools used to monitor EP. The existence of M. hyopneumoniae strains with different virulence characteristics and the molecular techniques available to detect them are also discussed.
Epidemiological and diagnostic tools to assess M. hyopneumoniae infection
The investigation and control of infectious disease is critically dependent on the availability of appropriate diagnostic tools. Several diagnostic methodologies are used to monitor M. hyopneumoniae infection.
Clinical signs
The main clinical sign of EP is the gradual onset of a chronic, non-productive cough, particularly in pigs at the finishing stage of the production cycle. Co-infection with the additional pathogens detailed previously results in fever, anorexia and laboured breathing. The onset of coughing, although gradual, can be inconsistent and of variable intensity depending on the infecting dose of M. hyopneumoniae. To identify pigs with non-productive coughs, animals need to be observed over a considerable time-span and should be encouraged to move. Quantifying the number of coughing pigs in a given period of time (the 'coughing score') has been used in transmission (Meyns et al., 2006; Marois et al., 2007) and pathogenesis studies (Morris et al., 1995a; Vicca et al., 2003) and has also been used in the assessment of the efficacy of M. hyopneumoniae vaccines under both natural (Maes et al., 1999; Moreau et al., 2004) and experimental (Thacker et al., 2000) conditions. However, given the lack of diagnostic specificity of coughing and that subclinically affected pigs would not display it, additional diagnostic modalities are required.
Abattoir surveillance
The assessment of respiratory disease within a pig herd by lung 'lesion scoring' at abattoir inspection is frequently used to estimate the incidence of EP and its impact on carcass market price. It has been estimated that the lungs of at least 30 animals should be examined to provide a reliable measure of the prevalence and severity of the pneumonia at herd level (Davies et al., 1995) . Such surveillance may also be useful in detecting subclinical disease which can adversely affect production during the fattening period. However EP lesions are not pathognomonic of M. hyopneumoniae infection as other organisms such as SIV can produce similar lesions (Thacker et al., 2001) .
Retrospective evaluation of the prevalence of EP in a herd by abattoir surveillance is limited in that this approach only identifies chronic lung lesions at the end of the production period and does not provide information regarding the ongoing respiratory health of the pigs during fattening (Noyes et al., 1990) . Similarly, the presence of additional bacterial pathogens such as A. pleuropneumoniae can cause severe pleuritis that mask EP lesions. Lesion resolution may lead to false-negative results or to an equivocal diagnosis of early mycoplasmosis (Sørensen et al., 1997) . The scoring systems used most frequently in EP abattoir surveillance are summarised in Table 1 . The subjectivity involved in the visual estimation of the proportion of lung consolidated and the lack of diagnostic specificity of these lesions, limit abattoir surveillance as a diagnostic approach and, therefore, the use of additional confirmatory methods is needed.
Bacteriological culture
The isolation of M. hyopneumoniae from affected lungs by bacteriological culture is considered the 'gold standard' diagnostic technique (Thacker, 2006) but isolation of the pathogen requires specialised Friis medium. Sørensen et al. (1997) compared the detection of M. hyopneumoniae by culture, immunofluorescence assay (IFA), enzymelinked immunosorbent assay (ELISA) and by a polymerase chain reaction (PCR) method and found culture the most sensitive technique particularly at the later stages of EP when fewer mycoplasma organisms were present. However, M. hyopneumoniae culture is laborious, time-consuming (isolation from field samples requires 4-8 weeks) and frequently culture media can become overgrown with M. hyorhinis or M. flocculare (Maes et al., 1996) .
Serological detection of M. hyopneumoniae infection
Serological tests are commonly used to monitor the health status of pig herds. Detection of antibodies to M. hyopneumoniae can be accomplished by ELISA and, less frequently, by complement fixation test. Antibody profiling of pig herds requires the simultaneous testing of groups of animals of different ages (transversal study) or the testing of one group of animals throughout the production cycle (longitudinal study) by ELISA. The ELISA in this context is a rapid, inexpensive and easily automated method that provides useful information on the presence of maternally-derived and acquired antibodies, as well as on the time required for animals to seroconvert. A blocking ELISA (IDEI, Mycoplasma hyopneumoniae EIA kit, Oxoid) and two indirect ELISA tests (HerdCheck, IDEXX and Tween 20-ELISA) are the most frequently used serological tests to detect antibodies to M. hyopneumoniae. Comparative studies have reported differing specificities and sensitivities between these kits (Pijoan, 1994; Strait et al., 2004; Ameri-Mahabadi et al., 2005; Erlandson, 2005) . When discrepancies in serological test results are identified, a Western blot immunoassay (WBI) targeting different M. hyopneumoniae antigens can be used as a confirmatory test (Ameri et al., 2006) . The utility of antibody profiling can be hindered by: variation in ELISA results depending on the test used (Ameri-Mahabadi et al., 2005; Erlandson, 2005) ; the inability of serology to differentiate natural infection from vaccination; lack of correlation between different measures of antibody titre; variations in the detection of antibodies to different strains of M. hyopneumoniae (Strait et al., 2004) ; significant variability in the time taken by animals to seroconvert.
Seroconversion under natural conditions is slower than in experimental studies. Although antibodies were detected 2-4 weeks after intratracheal infection of pigs with M. hyo-pneumoniae (Sheldrake et al., 1990; Kobisch et al., 1993) . Sørensen et al. (1997) reported seroconversion as early as 8 days post-infection (PI) in a proportion of pigs infected by aerosol, although the remaining animals required five further weeks to seroconvert. Under natural conditions, Morris et al. (1995b) detected seroconversion in a herd 3 weeks after contact exposure, with titres peaking around 11 weeks after exposure. In two other studies carried out under field conditions, seroconversion occurred mainly in grower-finishing units (8-24 weeks of age), between 6 and 9 weeks PI (Andreasen et al., 2000; Leon et al., 2001) . The delay in seroconversion associated with infection with this pathogen may partly be due to the fact that M. hyopneumoniae attaches to the ciliated respiratory epithelium and does not invade the pulmonary tissue to the same extent as other pathogens. This may result in slower presentation of mycoplasma antigens to the host. Of further note is the fact that there is no correlation between antibody titres and protection against the infection (Maes et al., 1996) .
Detection of M. hyopneumoniae antigen
Although immunohistochemistry (IHC) and IFA specifically detect M. hyopneumoniae in lung tissue sections or smears, these techniques have the drawback that a diagnosis can only be made post-mortem. Moreover, only a small lung sample is tested when using these techniques, increasing the risk of a false-negative result if airway is not included in the sample (Cai et al., 2007) . Furthermore, test sensitivity may be compromised by improper tissue processing. The quality of the antibodies used in these methods may also limit specific detection given that polyclonal antibodies may link with other, closely related, Mycoplasma spp. (Cheikh Saad Bouh et al., 2003) .
Although IHC using monoclonal or polyclonal antibodies specific to M. hyopneumoniae on formalin-fixed, paraffin-embedded lung sections allows the pathologist to correlate the presence of mycoplasma antigen with EP lesions (Sarradell et al., 2003; Rodriguez et al., 2004) , the technique is not routinely used in diagnostic laboratories due to its limited sensitivity. Direct (Kobisch et al., 1978) and indirect IFAs (Piffer and Ross, 1985) have been used to localise M. hyopneumoniae antigen in Madec and Kobisch (1982) 1-4 points per lobe depending on percentage of lobe affected 0 points = no lesions; 1 point = <25% of lobe; 2 points = 25-49%; 3 points = 50-74%; and 4 points >75%. Points for each of the seven lobes.
28 Morrison et al. (1985) Percentage of lobe affected 10 10 7 7 30 30 6 100 Straw et al. (1986) Percentage of lobe affected 10 10 10 10 25 25 10 100 Christensen et al. (1999) Percentage of lobe affected 7 4 15 9 35 25 5 100 porcine lungs. The IFA has also been compared with PCR as a diagnostic technique in pathogenesis and transmission studies (Sørensen et al., 1997; Vicca et al., 2003; Meyns et al., 2006) . A positive IFA test is associated with the more acute stage of EP when the mycoplasmal load is high, in contrast with the low sensitivity of this assay in more chronic disease when lower numbers of mycoplasma organisms are likely to be present (Ross, 1999) . A further limitation of the IFA is that in the frozen tissue sections used, artefactual tissue fragmentation may obscure morphological features.
Molecular detection methods

In situ hybridisation
In situ hybridization (ISH) has been used to detect and specifically locate M. hyopneumoniae DNA in formalinfixed, paraffin-embedded lung tissue of naturally (Kwon and Chae, 1999) and experimentally infected pigs (Kwon et al., 2002) . This technique uses a digoxigenin-labelled specific probe targeting a repetitive sequence of the M. hyopneumoniae genome. A fluorescent oligonucleotide probe targeting 16S ribosomal DNA has also been used for species-specific identification of M. hyopneumoniae, M. hyosynoviae, and M. hyorhinis (Boye et al., 2001) . Drawbacks of this method are that it requires post-mortem samples and it is relatively time-consuming and therefore not suitable for rapid diagnosis.
Polymerase chain reaction
Several PCR techniques for M. hyopneumoniae DNA detection in different sample types have been described (Table 2) . These PCR methods are more rapid than bacteriological culture and are relatively inexpensive to perform (Calsamiglia et al., 1999a) . However the confounding significance of sample contamination is much higher with PCR. Given that M. hyopneumoniae DNA from both live and dead organisms is amplified, the identification of PCR positive animals raises the question of whether such pigs have active infection or not. Since M. hyopneumoniae attaches to the ciliated epithelium of the airways, the best samples to detect M. hyopneumoniae by PCR are tracheo-bronchial swabs or bronchoalveolar lavage fluid (BALF). Tracheo-bronchial swabs and BALF are equally predictive of infection in both live (Marois et al., 2008) and dead (Kurth et al., 2002) experimentally infected pigs. The use of PCR to detect M. hyopneumoniae in lung tissue has produced variable results. Moorkamp et al. (2008) suggested that lung samples are more appropriate than BALF in cases of moderate to severe EP, whereas Kurth et al. (2002) found lung tissue unreliable in this context.
Ideally, a test to detect the presence of a pathogen in a living animal should be easy to perform, rapid, inexpensive, and should provide data of use in the implementation of control measures. Although the detection of M. hyopneumoniae in the nasal cavities of living pigs by PCR might theoretically fit these criteria, pigs inoculated with M. hyopneumoniae intratracheally were found to have low numbers of organisms in their upper respiratory tract and only shed the organism intermittently (Kurth et al., 2002; Ruiz et al., 2002; . However, the use of PCR to diagnose natural infection from nasal swabs was found reliable and an association was found between the detection of M. hyopneumoniae in the nasal cavities and bronchi with lesions of EP (Sibila et al., 2004a) . Although the potential use of nasal swabs for nested (Sibila et al., 2007b) , the procedure is currently considered more useful for the monitoring of infection at a herd rather than at an individual animal level (Otagiri et al., 2005) . The detection of M. hyopneumoniae by PCR provides a more precise method of determining when animals become infected that using time for seroconversion to occur, as this may vary considerably (Morris et al., 1995b; Andreasen et al., 2000; Leon et al., 2001) .
Molecular typing techniques
Variations in the clinical course of EP (Vicca et al., 2002) and inconsistencies in the efficacy of vaccination have raised suspicions that M. hyopneumoniae isolates vary in virulence. Differences at the antigenic (Assuncao et al., 2005) , chromosomal (Frey et al., 1992; Stakenborg et al., 2005) , genomic (Lin, 2001; Minion et al., 2004; Madsen et al., 2007; Mayor et al., 2007a) and proteomic (Calus et al., 2007) levels have been reported between M. hyopneumoniae isolates and, finally Vicca et al. (2003) demonstrated differing virulence characteristics between such isolates. Differences in adhesion (de Castro et al., 2006) and transmission (Meyns et al., 2004; Marois et al., 2007) of the organism have been suggested but not clearly demonstrated.
From an epidemiological perspective, typing M. hyopneumoniae isolates would facilitate the understanding of the transmission of M. hyopneumoniae isolates within and between herds. Recently described molecular typing techniques (Table 3) suggest that one strain of M. hyopneumoniae infects a given herd, whereas the strains involved in different outbreaks vary Mayor et al., 2007b) .
Transmission
Transmission under field conditions M. hyopneumoniae may be introduced into a herd in two main ways: by direct transmission following the introduction of purchased, subclinically infected replacement gilts or other pigs; and by airborne transmission. The role of fomites is thought to be minimal (Batista et al., 2004) .
Direct transmission
Once in the herd, M. hyopneumoniae is transmitted between animals in aerosolised droplets generated by coughing and sneezing or may spread through direct contact. Infection may spread horizontally from infected to naïve pigs (Morris et al., 1995b) or vertically from sows to their piglets (Maes et al., 1996) .
Vertical transmission
Infected gilts and sows can transmit M. hyopneumoniae to newly introduced gilts, including vaccinated ani-mals . In addition to the introduction of such animals, the transmission dynamics also includes the ongoing infection of piglets by sows. In particular low parity sows or gilts have low levels of antibodies and excrete more mycoplasma organisms than do older sows (Maes et al., 1996; Fano et al., 2006) . However, based on a nPCR technique, it has been indicated that breeding sows from their second to seventh parity can remain persistently infected with M. hyopneumoniae (Calsamiglia and Pijoan, 2000) . More research is required to determine how sow parity affects the shedding of M. hyopneumoniae and the development of disease in their offspring
Horizontal transmission
Horizontal transmission of infection may occur between pen mates or, in continuous flow production systems, from older to younger animals. Moreover, airborne transmission of infection can occur between different barns or units within a herd. Once established, M. hyopneumoniae infection may persist in the respiratory tract of adult animals for up to 185 days (Fano et al., 2005a) . Persistently infected pigs typically have subclinical disease, are difficult to detect using currently available diagnostic tools and remain carriers, capable of transmitting the pathogen to susceptible animals (Ruiz et al., 2002; Pijoan, 2005) .
Horizontal transmission of M. hyopneumoniae between wild boar and domestic pigs has recently been suggested in France (Marois et al., 2006) and Slovenia (Vengust et al., 2006) . In the former study, M. hyopneumoniae DNA was detected by PCR in lung homogenates of 9% of the wild boars tested. Although preliminary, these findings suggest that wild boar are a potential reservoir of M. hyopneumoniae infection for domestic swine or vice versa.
Airborne transmission
Although the main source of transmission between pigs is considered to be direct contact with subclinically infected carrier animals, the spread of M. hyopneumoniae infection by aerosol has recently gained more significance (Desrosiers, 2004) . Airborne particles containing the microorganism are generated by sneezing and coughing, and are also exhaled by infected pigs (Stärk, 1999) . Goodwin (1985) suggested that aerosol transmission between farms may occur and that the risk of a herd becoming infected with M. hyopneumoniae was inversely related to the proximity of other pig farms. Zhuang et al. (2002) found that a pig herd's risk of becoming infected was closely associated with pig density in the area and with the distance to neighbouring farms. The minimum distance between pig farms to theoretically avoid airborne transmission has been calculated to be at least 3 km. In Denmark, Thomsen et al. (1992) proposed airborne transmission as a major source of M. hyopneumoniae infection in mycoplasma-free SPF pig herds and indicated that the risk of these herds becoming infected was greater when neighbouring infected herds were larger.
Other transmission routes
Apart from direct contact and airborne transmission, indirect transmission of infection through fomites has also been suggested (Goodwin, 1985) . However an investigation by Batista et al. (2004) concluded that when standard biosecurity protocols were followed by farm personnel in weekly contact with infected pigs, M. hyopneumoniae was not transmitted to naïve animals.
Transmission under experimental conditions
Experimental studies have been used to study M. hyopneumoniae transmission and the infection dynamics between pig populations of varying infection status. To evaluate and quantify the transmission of M. hyopneumoniae to nursery pigs under standardised experimental conditions, Meyns et al. (2004) used an adjusted reproduction ratio (R n ). This R n value expressed the mean number of secondary infections caused by one infectious piglet during a nursery period of 6 weeks where the virulence of the isolate was taken into account (Vicca et al., Table 3 Summary of molecular techniques used to genotype M. hyopneumoniae field strains (adapted from Stakenborg, 2005) 2003). The R n values for the high and low virulent isolates were 1.47 and 0.85, respectively, although this difference was not statistically significant. These results imply that one piglet infected before weaning is able to infect one to four pen mates during the nursery period. Under the experimental conditions of this study (Meyns et al., 2004) , the spread of M. hyopneumoniae between animals was slow.
Other experimental studies have demonstrated transmission of M. hyopneumoniae between pen mates by 7 (Marois et al., 2007) and 28 (Fano et al., 2005b) days PI. Fano et al. (2005a) reported directly and indirectly in-contact animals seroconverting 5 and 6 weeks later than experimentally inoculated pigs. Meyns et al. (2006) demonstrated that vaccination, with a commercially available vaccine, did not significantly reduce M. hyopneumoniae transmission with R n values of 2.38 and 3.51 in vaccinated and non-vaccinated animals, respectively. This finding confirms what has been observed in several field studies, that the number of vaccinated seropositive pigs gradually increases towards the end of the finishing period, indicating that M. hyopneumoniae can still circulate in vaccinated animals (Maes et al., 1999) .
Few experimental studies have focused on the airborne transmission of M. hyopneumoniae. Fano et al. (2005b) reported the transmission of M. hyopneumoniae via aerosol to sentinel pigs located in a trailer 6 m from pigs experimentally co-infected with M. hyopneumoniae and PRRSV. Three weeks after exposure, 4/10 sentinel animals were positive for M. hyopneumoniae by nPCR in nasal and bronchial swabs and exhibited microscopic lesions suggestive of EP. Cardona et al. (2005) detected M. hyopneumoniae DNA in air samples 1, 75 and 150 m from where the microorganism was aerosolised. Although the movement of M. hyopneumoniae by aerosol was demonstrated in this study, the capacity of this aerosol to successfully infect pigs was not. Ruiz et al. (2002) demonstrated different infection patterns among pigs sired by different boars suggesting a possible genetic component to the susceptibility of animals to M. hyopneumoniae infection. However, the small sample of animals studied and the fact that the role of sow genetics was not assessed, limited the conclusions that could be drawn.
Herd epidemiology: Infection and seroconversion dynamics
The clinical outcome of M. hyopneumoniae infection is dependent on environmental and management conditions and on the production system in operation. Among the various management conditions, all-in-all-out (AIAO) procedures may help in reducing the prevalence and severity of EP lesions (Maes et al., 1996) . In farrow-tofinish (FF) systems, in which piglets remain until slaughter, transmission of infection from sows to piglets and from older to younger pigs occurs. In contrast, in multi-site (MS) systems the stages of pig production are physically separated from each other and the 'flow' of animals is unidirectional (Harris and Alexander, 1999) . In both systems the reproductive herd comprises animals of different ages and of different physiologic status (i.e. breeding, gestation, farrowing and lactation) and new animals are introduced to this group on an ongoing basis.
There is little information on the prevalence of M. hyopneumoniae-infected sows or their potential to shed bacteria and infect their offspring. Calsamiglia and Pijoan (2000) reported that between 24% and 56% of nonvaccinated sows were positive for M. hyopneumoniae by nPCR in a MS system. However, Ruiz et al. (2003) and Sibila et al. (2008) found a lower percentage (between 0% and 10.5%) of M. hyopneumoniae-infected sows at farrowing in both MS and FF systems. These findings also suggested that the prevalence of M. hyopneumoniae infection in sows was not related to the production system in operation.
In MS systems, piglets may become infected prior to weaning (Goodwin et al., 1965; Calsamiglia and Pijoan, 2000) . Calsamiglia and Pijoan (2000) reported between 7.7% and 9.6% of pigs infected by 17 days of age, Ruiz et al. (2003) reported between 5.5% and 13.2% of piglets infected on a breeding unit at 19 days of age, and Sibila et al. (2007b) found between 0% and 6.4% of pigs from 1 to 3 weeks of age, infected. Fano et al. (2007) reported much higher infection rates of up to 51.8% in piglets at 17 days of age. Pijoan (2005) hypothesised that the prevalence of porcine mycoplasma infections in segregated production systems varies according to the prevalence of M. hyopneumoniae infection among pigs at weaning. Moreover, prevalence of M. hyopneumoniae nasal infection in recently weaned pigs has been suggested as a potential indicator of shedding by sows (Ruiz et al., 2003) and a possible predictor of the severity of EP in older animals (Fano et al., 2007; Sibila et al., 2007a,b) .
Although animals can be infected early in life in both FF and MS systems, different infection and disease pathogenesis patterns have been reported (Sibila et al., 2004b) . While in FF operations, infection of piglets at the nursery stage tends to be high and the percentage of infected pigs increases progressively with advancing age, this percentage in MS systems tends to decrease with age at the nursery stage and then to increase abruptly at fattening (Sibila et al., 2004b) , a situation mirrored in herds with PRDC (Dee, 1996) .
Detection of M. hyopneumoniae infection in a herd does not necessarily imply that this pathogen is the main causative agent of any existing respiratory problem. Sibila et al. (2004b) identified farms with subclinical or clinical EP depending on their M. hyopneumoniae nPCR profile. A farm was considered to have subclinical EP when the proportion of infected pigs at different ages was low even when coughing was present. However herds with a high and increasing proportion of M. hyopneumoniae-infected pigs with concomitant coughing were considered clinically affected.
Several epidemiological studies describe M. hyopneumoniae seroconversion dynamics (Calsamiglia et al., 1999b; Leon et al., 2001; Vicca et al., 2002; Sibila et al., 2004b; Vigre et al., 2004) . Under field conditions, there is a progressive decrease in the numbers of pigs with maternal antibodies followed by a slow increase in the numbers of seropositive animals towards the finishing stage of production (Calsamiglia et al., 1999b) . Although the median half-life of maternal antibody against M. hyopneumoniae is approximately 16 days (Morris et al., 1994) , they may persist for 9 weeks when initial titres are high (Wallgren et al., 1998) . Persistence of maternal antibody to M. hyopneumoniae in piglets is also dictated by the level of antibody in the sow's serum (Wallgren et al., 1998) . Within a variable time-span after maternal antibodies wane, pigs seroconvert to M. hyopneumoniae (Sørensen et al., 1997; Vigre et al., 2004) although the waning of maternal antibodies may not be as significant in M. hyopneumoniae-vaccinated herds (Sibila et al., 2004b) . The fact that the number of seropositive animals gradually increases towards the end of the fattening period in both vaccinated and non-vaccinated herds suggests that antibodies induced by either natural infection or vaccination do not prevent further infection (Maes et al., 1998; Maes et al., 1999) .
Discussion
Although major efforts to control M. hyopneumoniae infection and its detrimental effects have been made, significant economic losses in pig production worldwide due to EP remain (Thacker, 2006) . Effective control requires a number of actions including establishing and monitoring the extent of disease, reducing transmission of infection and developing an appropriate vaccination strategy.
Establishing and monitoring the extent of EP in pig herds now typically utilises ELISA, PCR and abattoir surveillance methods. Necropsy is also useful, particularly when accompanying PRDC is suspected. Given that each of these diagnostic techniques has the limitations outlined previously, their use in combination is required to optimise diagnostic accuracy.
Reducing M. hyopneumoniae transmission between animals requires particular attention to critical transmission points. At weaning, M. hyopneumoniae-infected piglets may transmit the agent to nursery and finishing sites. Also, by the time animals are moved from the nursery to the finishing units, many animals have low levels of maternal antibodies (Leon et al., 2001) and are thus more susceptible to infection. Furthermore, the possibility of the airborne transmission of M. hyopneumoniae between farms or between production units within a herd should also be considered.
The development of an appropriate vaccination strategy may involve vaccination of piglets, sows, or both, against M. hyopneumoniae. Although currently available vaccines reduce the extent of EP lesions in vaccinated piglets, the vaccine does not protect animals against infection . Sow vaccination can control EP by transferring colostral-derived immunity to the piglets and thus reducing vertical transmission (Sibila et al., 2007a) . Further studies will be required to determine the relative effectiveness of these strategies and in particular to look at the protective efficacy of vaccination against potentially more virulent field isolates.
Experimental transmission models are useful in estimating the effects of treatment and control measures on the spread of M. hyopneumoniae infection but the results of such work must be treated with a degree of caution as the infecting dose in experimental situations is likely to be larger than under field conditions. Such larger challenge doses may explain the more rapid seroconversion observed in experimentally relative to naturally infected animals (Fano et al., 2005a) .
Although M. hyopneumoniae is usually considered primarily a respiratory pathogen, recent studies have reported the isolation of this agent from the liver, spleen and kidneys of experimentally (Le Carrou et al., 2006) and in-contact infected pigs (Marois et al., 2007) . This finding suggests that M. hyopneumoniae infection is not always restricted to the respiratory tract and merits further investigation.
Conclusions
The effective control of M. hyopneumoniae-infection and of consequent EP in pig herds requires a number of actions including the establishment and monitoring of the extent of the disease, the use of techniques such as the molecular typing of isolates to analyse infection transmission patterns and the design of effective vaccines and vaccination strategies.
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